The weak point may not be the product
Much of the discussion around quality in the supplement and health industry focuses on what happens before a product reaches the market.
Which ingredients are used? At what dose? What evidence supports them? Is the formulation appropriate? Are the claims compliant?
These are essential questions.
But there is another part of the product journey that receives considerably less attention: what happens to that evidence once the product enters marketing.
A carefully formulated product may begin with a nuanced scientific rationale. By the time the same rationale has passed through a marketing team, an agency, a creator brief and finally a 20-second social media video, the message can look very different.
“May support” becomes “will improve.”
An association becomes a mechanism.
Evidence from one population is applied to another.
Research on an individual nutrient becomes a promise about the finished product.
A personal experience becomes something that sounds remarkably similar to a health claim.
None of these shifts needs to be dramatic. In fact, that is precisely why they are easy to miss.
Health communication has a translation problem
There is an inherent tension in health marketing.
Science is conditional. Marketing rewards clarity.
Scientific evidence contains uncertainty, population differences, effect sizes, limitations and context. Social media favours short messages, strong hooks and easily understood outcomes.
The answer cannot be to communicate scientific papers verbatim to consumers. Good health communication requires translation.
But translation and exaggeration are not the same thing.
This distinction becomes particularly important when brands work with influencers and content creators.
The creator may receive a product, a campaign concept and a list of key messages. They are then expected to transform those materials into content that feels personal and authentic.
That model works well for many consumer products.
Health is different.
The moment a creator begins explaining what a nutrient, supplement or health product “does”, they are communicating information that may have scientific, clinical and regulatory implications.
That requires a different infrastructure behind the content.
Influencer marketing is exposing a larger industry problem
Food Supplements Europe recently published guidance on responsible influencer marketing of food supplements.
The guidance addresses transparency, health and nutrition claims, responsibilities between brands and creators, content review and monitoring.
It is useful guidance.
But from our perspective at Axiona, it also points to something broader.
Influencer marketing has not created the problem of inaccurate health communication. It has made an existing problem more visible.
Health companies increasingly operate across multiple communication layers: websites, social media, customer service, retailers, practitioners, ambassadors, influencers, podcasts and educational content.
Every additional layer creates another point at which the original scientific rationale can be simplified, strengthened or misunderstood.
This means clinical and scientific quality assurance cannot stop when the product specification is approved.
It has to follow the communication.
The creator is often the final link in a much longer chain
It is easy to focus responsibility on the influencer because that is the person consumers see.
But if a creator makes an inappropriate health statement, there is another question worth asking:
What information and framework did the company provide?
Creators should be responsible for what they publish. They should also understand
What we do at Axiona
Axiona helps companies in nutrition, supplements and health innovation strengthen the clinical and scientific quality behind their products and communication.
We bridge the gap between science, product and market through clinical quality assurance, product development and professional education - helping brands communicate with greater accuracy, consistency and credibility.
Building something in health? Let’s make sure the clinical quality is as strong as the idea behind it.